{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:04:27Z","timestamp":1784642667352,"version":"3.55.0"},"reference-count":17,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In patients with acute severe ulcerative colitis (ASUC) who have received infliximab rescue therapy, the need for and timing of further steroid therapy is unclear. This brief communication explores contemporary clinical practice across Australia regarding corticosteroid management following rescue therapy in ASUC. By describing variability in real\u2010world practice patterns and potential risks and benefits of different approaches, this article highlights current evidence gaps and the need for further studies to better inform clinical practice.<\/jats:p>","DOI":"10.1111\/imj.70560","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:43:15Z","timestamp":1784641395000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Corticosteroid therapy following infliximab rescue in acute severe ulcerative colitis: should they be continued?"],"prefix":"10.1111","author":[{"given":"Benjamin","family":"Ngoi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology The Queen Elizabeth Hospital  Adelaide South Australia Australia"},{"name":"School of Medicine, Faculty of Health and Medical Sciences Adelaide University  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan Anh","family":"Duong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Wollongong Hospital  Wollongong New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"Bryant","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology The Queen Elizabeth Hospital  Adelaide South Australia Australia"},{"name":"School of Medicine, Faculty of Health and Medical Sciences Adelaide University  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7960-2650","authenticated-orcid":false,"given":"Jane M.","family":"Andrews","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences Adelaide University  Adelaide South Australia Australia"},{"name":"Department of Gastroenterology and Hepatology Royal Adelaide Hospital  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7748-2165","authenticated-orcid":false,"given":"Kate D.","family":"Lynch","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences Adelaide University  Adelaide South Australia Australia"},{"name":"Department of Gastroenterology and Hepatology Royal Adelaide Hospital  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/2050640620977405","article-title":"Long\u2010term outcomes of acute severe ulcerative colitis in the rescue therapy era: a multicentre cohort study","volume":"9","author":"Festa S","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"e_1_2_3_3_1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrgastro.2016.116","article-title":"Acute severe ulcerative colitis: from pathophysiology to clinical management","volume":"13","author":"Hindryckx P","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"e_1_2_3_4_1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove SC","year":"1955","journal-title":"Br Med J"},{"key":"e_1_2_3_5_1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","article-title":"The pattern and outcome of acute severe colitis","volume":"4","author":"Dinesen LC","year":"2010","journal-title":"J Crohns Colitis"},{"key":"e_1_2_3_6_1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gut.38.6.905","article-title":"Predicting outcome in severe ulcerative colitis","volume":"38","author":"Travis SP","year":"1996","journal-title":"Gut"},{"key":"e_1_2_3_7_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.14740\/gr2086","article-title":"Efficacy and safety of tofacitinib for acute severe ulcerative colitis: a systematic review and meta\u2010analysis","volume":"18","author":"Brennan G","year":"2025","journal-title":"Gastroenterology Res"},{"key":"e_1_2_3_8_1","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ibd\/izae191","article-title":"Upadacitinib for acute severe ulcerative colitis: a systematic review","volume":"31","author":"Damianos JA","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_3_9_1","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/ecco-jcc\/jjad036","article-title":"Tofacitinib for acute severe ulcerative colitis: a systematic review","volume":"17","author":"Steenholdt C","year":"2023","journal-title":"J Crohns Colitis"},{"key":"e_1_2_3_10_1","article-title":"Acute severe ulcerative colitis patients from Asia have lower colectomy risk than patients from Australasia","author":"Fernandes RG","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_3_11_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001343","article-title":"Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort","volume":"11","author":"Ovesen PD","year":"2024","journal-title":"BMJ Open Gastroenterol"},{"key":"e_1_2_3_12_1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cgh.2020.06.036","article-title":"Effect of concomitant therapy with steroids and tumor necrosis factor antagonists for induction of remission in patients with Crohn's disease: a systematic review and pooled meta\u2010analysis","volume":"19","author":"Faleck DM","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_3_13_1","volume-title":"Corticosteroid Adverse Effects","author":"Yasir M","year":"2024"},{"key":"e_1_2_3_14_1","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1177\/00031348221080421","article-title":"The impact of steroids and inflammatory bowel disease in colectomies in the era of enhanced recovery","volume":"89","author":"Dinallo AM","year":"2023","journal-title":"Am Surg"},{"key":"e_1_2_3_15_1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.amjsurg.2015.07.002","article-title":"Impact of chronic steroid use on outcomes of colorectal surgery","volume":"210","author":"Moghadamyeghaneh Z","year":"2015","journal-title":"Am J Surg"},{"key":"e_1_2_3_16_1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691480","article-title":"Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice","volume":"12","author":"Bruscoli S","year":"2021","journal-title":"Front Immunol"},{"key":"e_1_2_3_17_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00384-017-2903-8","article-title":"Early colectomy in steroid\u2010refractory acute severe ulcerative colitis improves operative outcome","volume":"33","author":"Saha SK","year":"2018","journal-title":"Int J Color Dis"},{"key":"e_1_2_3_18_1","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","article-title":"British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025","volume":"74","author":"Moran GW","year":"2025","journal-title":"Gut"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70560","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.70560","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:43:18Z","timestamp":1784641398000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.70560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":17,"alternative-id":["10.1111\/imj.70560"],"URL":"https:\/\/doi.org\/10.1111\/imj.70560","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"2026-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"imj.70560"}}